Understanding Cardiolipin Antibody IgA: Normal vs Optimal Ranges

?What is Cardiolipin Antibody IgA?

Cardiolipin antibody IgA (aCL IgA) is an immunoglobulin that targets cardiolipin, a phospholipid found on cell membranes and in mitochondria. This antibody is one component of antiphospholipid syndrome (APS) testing and may be associated with thrombotic and obstetric complications. It is typically measured in serum and reported in standardised units.

!Why It Matters

Elevated cardiolipin antibody IgA may suggest antiphospholipid syndrome or related autoimmune conditions, which can be associated with increased risk of blood clots, pregnancy loss, and thrombotic events. Testing for this marker helps identify individuals who may benefit from targeted monitoring or anticoagulation therapy. A single positive result warrants clinical correlation and repeat testing, as it is not diagnostic on its own.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Recurrent blood clots (venous or arterial)
• Recurrent pregnancy loss or miscarriage
• Stroke or transient ischemic attack at young age
• Livedo reticularis (lace-like skin discoloration)
• Thrombocytopenia (low platelet count)

How to Improve Your Levels

• 1Work with a rheumatologist or haematologist if APS is suspected or confirmed
• 2Follow prescribed anticoagulation or antiplatelet therapy as directed
• 3Maintain adequate hydration to support vascular health
• 4Manage underlying autoimmune conditions with appropriate medical care
• 5Avoid known prothrombotic triggers (e.g. prolonged immobility, hormonal therapies)
• 6Attend regular follow-up testing to monitor antibody levels and clinical status

When to Test

Testing is indicated in individuals with personal or family history of thrombosis, recurrent miscarriage, stroke or thrombotic events at young age, or when antiphospholipid syndrome is clinically suspected. Repeat testing 12 weeks after initial positive result is recommended for diagnosis confirmation.

Related Biomarkers